CSIMarket



Tabula Rasa Healthcare inc.  (TRHC)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

TRHC's Revenue Growth by Quarter and Year

Tabula Rasa Healthcare's Revenue results by quarter and year




TRHC Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 85.69 77.05 73.22
III Quarter September - 86.59 70.51 74.27
II Quarter June 72.60 82.31 76.83 76.26
I Quarter March 67.11 76.68 72.83 60.96
FY   139.71 331.27 297.22 284.71



TRHC Revenue second quarter 2022 Y/Y Growth Comment
Tabula Rasa Healthcare Inc. reported fall in Revenue in the second quarter 2022 by -11.8% to $ 72.60 millions, from the same quarter in 2021.
The decline in the second quarter 2022 Tabula Rasa Healthcare Inc.'s Revenue compares unfavorably to the Company's average Revenue growth of 2.62%.

Looking into second quarter 2022 results within Healthcare Facilities industry 52 other companies have achieved higher Revenue growth. While Tabula Rasa Healthcare Inc.' s Revenue decrease of -11.8% ranks overall at the positon no. 2858 in the second quarter 2022.




TRHC Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 11.21 % 5.23 % 0.8 %
III Quarter September - 22.81 % -5.06 % 36.48 %
II Quarter June -11.8 % 7.13 % 0.75 % 56.91 %
I Quarter March -12.48 % 5.29 % 19.47 % 38.73 %
FY   - 11.46 % 4.39 % 29.65 %

Financial Statements
Tabula Rasa Healthcare's second quarter 2022 Revenue $ 72.60 millions TRHC's Income Statement
Tabula Rasa Healthcare's second quarter 2021 Revenue $ 82.31 millions Quarterly TRHC's Income Statement
New: More TRHC's historic Revenue Growth >>


TRHC Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -1.04 % 9.28 % -1.41 %
III Quarter September - 5.2 % -8.23 % -2.61 %
II Quarter June 8.18 % 7.34 % 5.49 % 25.1 %
I Quarter March -21.68 % -0.48 % -0.53 % -16.08 %
FY (Year on Year)   - 11.46 % 4.39 % 29.65 %




Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #53
Healthcare Sector #438
Overall #2858

Revenue Y/Y Growth Statistics
High Average Low
11.69 % 2.62 % -3.02 %
(Jun 30 2019)   (Jun 30 2022)
Revenue second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #53
Healthcare Sector #438
Overall #2858
Revenue Y/Y Growth Statistics
High Average Low
11.69 % 2.62 % -3.02 %
(Jun 30 2019)   (Jun 30 2022)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Tabula Rasa Healthcare's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
33.49 % 4.26 % -21.68 %
(Dec 31 2018)  


TRHC's II. Quarter Q/Q Revenue Comment
Tabula Rasa Healthcare inc. achieved in the II. Quarter 2022 above company average sequential Revenue increase of 8.18%, to $ 72.60 millions, from $67.11 millions in the first quarter.
Tabula Rasa Healthcare is undergoing a remarkable growth, not only claiming above average gain, and also increasing pace.

Within Healthcare Facilities industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Tabula Rasa Healthcare's Revenue growth quarter on quarter, overall rank is 1433.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #14
Healthcare Sector #266
Overall #1433
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #14
Healthcare Sector #266
Overall #1433
Revenue Q/Q Growth Statistics
High Average Low
33.49 % 4.26 % -21.68 %
(Dec 31 2018)  


TRHC's II. Quarter Q/Q Revenue Comment
Tabula Rasa Healthcare inc. achieved in the II. Quarter 2022 above company average sequential Revenue increase of 8.18%, to $ 72.60 millions, from $67.11 millions in the first quarter.
Tabula Rasa Healthcare is impressively improving, not just reporting above average growth, and additionally increasing speed.

Within Healthcare Facilities industry 13 other companies have achieved higher Revenue quarter on quarter growth. While Tabula Rasa Healthcare's Revenue growth quarter on quarter, overall rank is 1433.


Tabula Rasa Healthcare's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Revenue 12 Months Ending $ 311.98 $ 321.69 $ 331.26 $ 322.63 $ 306.55
Y / Y Revenue Growth (TTM) 1.77 % 6.85 % 11.45 % 9.97 % 3.16 %
Year on Year Revenue Growth Overall Ranking # 2284 # 1572 # 1457 # 1235 # 2335
Seqeuential Revenue Change (TTM) -3.02 % -2.89 % 2.68 % 5.25 % 1.82 %
Seq. Revenue Growth (TTM) Overall Ranking # 2858 # 2027 # 1396 # 1514 # 3366




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2022 period, Tabula Rasa Healthcare's cumulative twelve months Revenue were $ 312 millions, company would post below average annual Revenue growth of 1.82% year on year, if the fiscal year would end at Jun 30 2022.
A slow-down in the Tabula Rasa Healthcare's Revenue growth from the 67.11% growth in Mar 31 2022.

In the Healthcare sector 314 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1572 to 2284.

Revenue TTM Q/Q Growth Statistics
High Average Low
11.69 %
2.62 %
-3.02 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 53
Healthcare Sector # 315
Overall # 2284

Revenue TTM Y/Y Growth Statistics
High Average Low
438.45 %
79.04 %
1.52 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 53
Sector # 438
S&P 500 # 2858
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2022 period, Tabula Rasa Healthcare's cumulative twelve months Revenue were $ 312 millions, company would post below average annual Revenue growth of 1.52% year on year, if the fiscal year would end at Jun 30 2022.
A slow-down in the Tabula Rasa Healthcare's Revenue growth from the 67.11% growth in Mar 31 2022.

In the Healthcare sector 314 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1572 to 2284.

Revenue TTM Q/Q Growth Statistics
High Average Low
11.69 %
2.62 %
-3.02 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 53
Healthcare Sector # 315
Overall # 2284

Revenue TTM Y/Y Growth Statistics
High Average Low
438.45 %
79.04 %
1.52 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 53
Sector # 438
S&P 500 # 2858




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TRHC's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TRHC's Competitors
Revenue Growth for Tabula Rasa Healthcare's Suppliers
Revenue Growth for TRHC's Customers

You may also want to know
TRHC's Annual Growth Rates TRHC's Profitability Ratios TRHC's Asset Turnover Ratio TRHC's Dividend Growth
TRHC's Roe TRHC's Valuation Ratios TRHC's Financial Strength Ratios TRHC's Dividend Payout Ratio
TRHC's Roa TRHC's Inventory Turnover Ratio TRHC's Growth Rates TRHC's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2022
Edwards Lifesciences Corporation-0.15%$ -0.153 millions
Chemed Corporation-0.18%$ -0.182 millions
Heska Corporation-0.39%$ -0.387 millions
Ati Physical Therapy Inc.-0.45%$ -0.451 millions
Berkeley Lights Inc.-0.52%$ -0.519 millions
Organon and Co.-0.63%$ -0.627 millions
Outset Medical Inc.-0.63%$ -0.631 millions
Accuray Incorporated-0.82%$ -0.823 millions
Travere Therapeutics Inc.-0.82%$ -0.824 millions
Amedisys Inc-1.11%$ -1.112 millions
Teleflex Incorporated-1.25%$ -1.252 millions
Y mabs Therapeutics inc.-1.41%$ -1.406 millions
Organogenesis Holdings Inc.-1.46%$ -1.457 millions
Mimedx Group Inc.-1.88%$ -1.881 millions
Acorda Therapeutics inc.-2.31%$ -2.309 millions
Community Health Systems Inc.-2.43%$ -2.428 millions
Alpha Pro Tech Ltd.-2.43%$ -2.432 millions
Orthofix Medical Inc.-2.74%$ -2.738 millions
Quotient Limited-3.03%$ -3.026 millions
Teva Pharmaceutical Industries Limited-3.17%$ -3.171 millions
Neurometrix Inc.-3.40%$ -3.397 millions
Royalty Pharma Plc-3.43%$ -3.425 millions
Bio rad Laboratories Inc.-3.47%$ -3.468 millions
Healthlynked Corp.-3.63%$ -3.630 millions
Eli Lilly And Company-3.74%$ -3.740 millions
Laboratory Corporation Of America Holdings-3.74%$ -3.744 millions
Quest Diagnostics Inc-3.80%$ -3.804 millions
Livanova Plc-3.91%$ -3.906 millions
Align Technology inc.-4.08%$ -4.081 millions
Icad Inc.-4.17%$ -4.175 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CNGL's Profile

Stock Price

CNGL's Financials

Business Description

Fundamentals

Charts & Quotes

CNGL's News

Suppliers

CNGL's Competitors

Customers & Markets

Economic Indicators

CNGL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071